bf/NASDAQ:HSKA_icon.png

COM:HESKA

Heska

  • Stock

USD

Last Close

119.99

12/06 20:00

Market Cap

1.31B

Beta: -

Volume Today

330.89K

Avg: -

Company Overview

Metric
Company NameHeska CorporationHippo Manager
SymbolHSKA
MSH IDCOM:HESKACOM:HIPPOMANAGER
MarketSTOCKSPRIVATE
SectorHealthcareHealthcare & Health Services
IndustryMedical - DevicesSoftware
CountryUS
Stage
Employee Count80811
Websiteheska.comhippomanager.com
LinkedIn
Founders

Market Metrics

Metric
Market Cap1.31B
Enterprise Value
Monthly Web Traffic2.55K
Web Traffic Growth8.62
Valuation
Raised Capital

Financial Performance

Metric
Revenue257.31M
Revenue (LTM)
Revenue (NTM)
Gross Profit111.17M
EBITDA-20.30M
Operating Income-20.30M
Net Income-18.42M
EPS-1.78
Diluted EPS-1.78
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Growth Metrics

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Profitability Ratios

Metric
Gross Profit Margin0.43
Operating Profit Margin-0.06
EBITDA Margin-0.08
Net Profit Margin-0.07
Return on Equity-0.03
Return on Assets-0.02
Return on Capital Employed-0.02

Valuation Multiples

Metric
P/E Ratio-67.05
P/B Ratio2.98
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio10.17
EV Multiple-101.54

Operational Metrics

Metric
Days Sales Outstanding52.32
Days Payables Outstanding30.73
Days Inventory Outstanding318.73
Operating Cycle422.34
Cash Conversion Cycle361.53
Asset Turnover0.32

Cash Flow Metrics

Metric
Operating Cash Flow-21.81M
Free Cash Flow-23.93M
Cash Flow to Debt-0.11
Operating Cash Flow/Sales-0.08
Free Cash Flow Yield-0.01

Balance Sheet Metrics

Metric
Cash & Equivalents156.62M
Accounts Receivable-1.49M
Inventory60.05M
Goodwill135.92M
Debt to Capitalization0.21
Debt to Assets0.18
Current Ratio5.64
Quick Ratio3.82

Efficiency Metrics

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue0.05
R&D to Revenue0.04
SG&A to Revenue0.28